PL
PL · PL · PL-100474776
Opdualag
ATC L01FY02
Last synced from URPL (Poland) on
Identification
ManufacturerBristol-Myers Squibb Pharma EEIG
CountryPL (PL)
ATC codeL01FY02
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 1
- gtin08027950800476
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "240 mg + 80 mg",
"packaging": "08027950800476 ¦ Rpz ¦ EU/1/22/1679/001 ¦ 147268\n1 fiol. 20 ml",
"substance": "Nivolumabum 240 mg + Relatlimabum 80 mg",
"common_name": "Niwolumab + Relatlimab",
"pl_product_id": "100474776",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code L01FY02.
- 🇨🇭OpdualagBristol-Myers Squibb SA
- DKOpdualagBristol-Myers Squibb Pharma EEIG
- ISOpdualagBristol-Myers Squibb Pharma EEIG*
- NOOpdualagBristol-Myers Squibb Pharma EEIG (1)
- FIOpdualagBristol-Myers Squibb Pharma EEIG
- CZOPDUALAGBristol-Myers Squibb Pharma EEIG, Dublin
- CAOPDUALAGBRISTOL-MYERS SQUIBB CANADA
- BEOpdualag 240 mg - 80 mgBristol-Myers Squibb Pharma
Access this data programmatically
Query Opdualag and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.